The company's just announced the hospital discharge of the first patient following its clinical surgical aortic valve replacement (SAVR) trial.
Admedus Ltd 'in good shape' with minimal disruption to supply chain as it advances SAVR trial
Quick facts: Anteris Technologies Ltd
Price: 3.5 AUD
Market Cap: $20.69 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE